Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1375791 | Bioorganic & Medicinal Chemistry Letters | 2008 | 5 Pages |
Abstract
High throughput screening of our compound library revealed a series of N-pyridyl-3-benzamides as low micromolar agonists of the human TRPV1 receptor. Synthesis of analogs in this series led to the discovery of a series of N-quinolin-3-yl-benzamides as low nanomolar antagonists of human TRPV1.
Graphical abstractThe synthesis and biological activity of a series of 3-quinolinyl p-aminobenzamide TRPV1 antagonists are reported.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Michele C. Jetter, James J. McNally, Mark A. Youngman, Mark E. McDonnell, Adrienne E. Dubin, Nadia Nasser, Sui-Po Zhang, Ellen E. Codd, Ray W. Colburn, Dennis R. Stone, Michael R. Brandt, Christopher M. Flores, Scott L. Dax,